REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/06/2025
Voltar para busca
Dado oficial do USPTO
INVENTAGE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
10/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10
Data de depósito
05/07/2019
Data de registro
09/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/06/2020
Última transação
10/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Seongnam-si, G, KR
Examinador
KLEINMAN, CORINNE
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Inventage Lab Inc.
Representantes
Paul G. Johnson Maschoff Brennan
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicinal infusions for treating dementiadiabetesobesityandropathyalopeciaincurable diseasechronic diseaselipolysisboosting the immune system; Medicinal infusions for treating dirofilaria immitis diseasesinfectious diseasesskeletal and muscular disorderscardiovascular and circulatory diseasesnervous system diseasesocular disordersrespiratory diseasesgastrointestinal diseasesendocrine diseaseskidney diseaseshormonal diseasesoncological diseases and disorders of animals; implantable medicines in the nature of surgical implants comprised of living tissues; pharmaceutical compositions for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti-infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; pharmaceutical compositions for animal skincare; pharmaceutical compositions for skin care; pharmaceutical compositions for treating dirofilaria immitis diseasesinfectious diseasesskeletal and muscular disorderscardiovascular and circulatory diseasesnervous system diseasesocular disordersrespiratory diseasesgastrointestinal diseasesendocrine diseaseskidney diseaseshormonal diseasesoncological diseases and disorders of animals; medicines for human purposesmedicines for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; drugs in the nature of pharmaceutical preparations for medical purposesfor the treatment of oncologicalgastrointestinalmetabolicchronicendocrinerespiratoryneurological and ophthalmic diseases and disorders; therapeutic drugs and agents in the nature of therapeutic pharmaceutical and agents for the treatment of oncologicalgastrointestinalmetabolicchronicendocrinerespiratoryneurological and ophthalmic diseases and disorders; therapeutic drugs and agents in the nature of therapeutic pharmaceutical and agents for treating dirofilaria immitis diseasesinfectious diseasesskeletal and muscular disorderscardiovascular and circulatory diseasesnervous system diseasesocular disordersrespiratory diseasesgastrointestinal diseasesendocrine diseaseskidney diseaseshormonal diseasesoncological diseases and disorders of animals; chemical preparations for pharmaceutical purposesfor the treatment of oncologicalgastrointestinalmetabolicchronicendocrinerespiratoryneurological and ophthalmic diseases and disorders
Classe 10
Medical apparatus and instruments for use in endovascularcardiovascularendoscopy procedures; medical instruments for use in drug delivery systems; medical instruments for use in monitoring oxymetorygas analysisvital signsblood properties and respiratory events; medical instruments for use in treating osteoarthritisosteoporosisosteotraumatic injuriesdegenerative bone diseases and joint diseases; medical instruments to measure blood pressurecardiac output and other physiological and cardiovascular parameters; medical instruments for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; medical filler apparatus in the nature of synthetic filler and extender material to serve as replacement for bone; medical apparatus and instrumentsinfusion and injection devices for administering pharmaceuticals; diagnostic apparatus and instruments for medical purposesmedical diagnostic apparatus for testing blood sugar levelscancer cellsDNAurinary proteincholesterol level; injection device for pharmaceuticals; medical apparatusinfusion and injection devices for administering pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/01/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/10/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/10/2020
FIMP
FINAL DISPOSITION PROCESSED
02/10/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/09/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/03/2020
PUBO
PUBLISHED FOR OPPOSITION
24/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/01/2020
RFNT
REFUSAL PROCESSED BY IB
19/10/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/10/2019
RFRR
REFUSAL PROCESSED BY MPU
01/10/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/09/2019
CNRT
NON-FINAL ACTION WRITTEN
24/09/2019
DOCK
ASSIGNED TO EXAMINER
23/09/2019
MAFR
APPLICATION FILING RECEIPT MAILED
17/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/09/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INVENTAGE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.